Journal of Hepatology
Volume 53, Issue 2 , Pages 298-306 , August 2010

Mechanisms of TNFα-induced cardiac dysfunction in cholestatic bile duct-ligated mice: Interaction between TNFα and endocannabinoids

  • Ying-Ying Yang

      Affiliations

    • Liver Unit, Faculty of Medicine, University of Calgary, Calgary, Canada
    • Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Department of Preventive Medicine, Institute of Public Health, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • These two authors contributed equally to this paper.
    • ,
  • Hongqun Liu

      Affiliations

    • Liver Unit, Faculty of Medicine, University of Calgary, Calgary, Canada
    • These two authors contributed equally to this paper.
    • ,
  • Soon Woo Nam

      Affiliations

    • Liver Unit, Faculty of Medicine, University of Calgary, Calgary, Canada
    • ,
  • George Kunos

      Affiliations

    • Laboratory of Physiologic Studies, National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Samuel S. Lee

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Health Science Centre, 3330 Hospital Dr NW, Calgary, AB, Canada T2N 4N1. Fax: +1 403 270 0995.
    • Liver Unit, Faculty of Medicine, University of Calgary, Calgary, Canada

Received 8 December 2009 ,Revised 23 February 2010 ,Accepted 8 March 2010.

References 

  1. Heller J, Sogni P, Barriere E, Tazi KA, Chauvelot-Moachon L, Guimont MC, et al. Effects of lipopolysaccharide on TNFα production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol. 2000;33:376–381
  2. Lui J, Batkai S, Pacher P, Harvey-White J, Wagner JA, Cravatt BF, et al. Lipopolysacchoride induced anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NFκB independently of platelet-activating factor. J Biol Chem. 2003;278:45034–45039
  3. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotheraphy. Pharmacol Rev. 2006;58:389–462
  4. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704–711
  5. Batkai S, Mukhopadhyay P, Harvey-White J, Kechrid R, Pacher P, Kunos G. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. Am J Physiol Heart Circ Physiol. 2007;293:H1689–H1695
  6. Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct ligated rats. Gastroenterology. 2000;118:937–944
  7. Liu H, Song D, Lee SD. Role of heme oxygenase–carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol Gastrointest Liver Physiol. 2001;280:G68–G71
  8. Gaskari SA, Liu H, Moezi L, Li Y, Baik SK, et al. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol. 2005;146:315–323
  9. Papadakis KA, Targan SR. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology. 2000;119:1148–1157
  10. Kan H, Birkle D, Jain AC, Failinger C, Xie S, Finkel MS. P38 MAP kinase inhibitor reverses stress-induced cardiac myocyte dysfunction. J Appl Physiol. 2005;98:77–82
  11. Shao Z, Bhattacharya K, Hsich E, Park L, Walters B, Germann U, et al. C-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Cir Res. 2006;98:111–118
  12. Liu H, Lee SS. Nuclear factor-B inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy. Liver Int. 2008;28:640–648
  13. Zhao TC, Taher MM, Valerie KC, Kukreja RC. P38 triggers late preconditioning elicited by anisomycin in heart: involvement of NF-κB and iNOS. Circ Res. 2001;89:915–922
  14. Sheehan KC, Ruddle NH, Schreiber RD. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol. 1989;142:3884–3893
  15. Ward CA, Liu H, Lee SS. Altered cellular calcium regulatory systems in a rat model of cirrhotic cadiomyopathy. Gastroenterology. 2001;121:1209–1218
  16. Guimond A, Teletin M, Garo E, D’Sa A, Selloum M, Champy MF, et al. Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodeling in mice. Liver Int. 2007;27:854–864
  17. Georgiev P, Jochum W, Heinrich S, Jang JH, Nocito A, Dahm F, et al. Characterization of time-related changes after experimental bile duct ligation. Br J Surg. 2008;95:646–65621
  18. de Lago E, Ortega-Gutrierrez S, Ramos JA, Rodriguez MLL, Fernandez-Ruiz J. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions. Life Sci. 2007;80:979–988
  19. Ren J, Relling DP. Interaction between tumor necrosis factor-α and leptin-induced inhibition of cardiac contractile function in isolated ventricular myocytes. Cytokine. 2005;32:213–218
  20. Moezi L, Gaskari SA, Liu H, Baik SK, Dehpour AR, Lee SS. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB1 and VR1 receptor. Br J Pharmacol. 2006;149:898–908
  21. Binah O, Bomzon A, Blendis LM, Mordohovich D, Better OS. Obstructive jaundice blunts myocardial contractile response to isoprenaline in the dog: a clue to the susceptibility of jaundiced patients to shock?. Clin Sci. 1985;69:647–653
  22. Ma Z, Zhang Y, Huet PM, Lee SS. Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiac myopathy. J Hepatol. 1999;30:485–491
  23. Tavakoli S, Hajrasouliha AR, Jabehdar-Maralani P, Ebrahimi F, Sadeghipour H, Dehghani M, et al. Modulated hemodynamic response to clonidine in bile duct ligated rat: the role of nitric oxide. Eur J Pharmacol. 2006;542:148–153
  24. Watanable T, Jono H, Han J, Lim DJ, Li JD. Synergistic activation of NF-κB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha. Proc Natl Acad Sci USA. 2004;101:3563–3568
  25. Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiomyocytes characterization and regulation of iNOS expression and detection of iNOS activity in single cardiomyocytes in vitro. J Biol Chem. 1994;269:27580–27588
  26. Horton JW, Maass D, White J, Sanders B. Nitric oxide modulation of 22 TNF-α-induced cardiac contractile dysfunction is concentration dependent. Am J Physiol Heart Circ Physiol. 2000;278:H1955–H1965
  27. Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 2001;104:317–324
  28. Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka BK, Xiao RP. Β2-adrenergic receptor-induced p38MAPK activation is mediated by protein kinase A rather than by Gi and Gs in adult mouse cardiomyocytes. J Biol Chem. 2000;275:40635–40640
  29. Lee SS, Marty J, Manitz J, Samain E, Braillon A, Lebrec D. Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats. Hepatology. 1990;12:481–485
  30. Takashima S, Hori M, Kitakaze M, et al. Superoxide dismutase restores contractile and metabolic dysfunction through augmentation of adenosine release in coronary microembolization. Circulation. 1993;263:1353–1357
  31. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85–94
  32. Yang YY, Lee KC, Huang YT, Lin HC, Hou MC, Lee FY, et al. Inhibition of hepatic tumor necrosis factor-α attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers. Liver Int. 2009;29:678–685

PII: S0168-8278(10)00328-4

doi: 10.1016/j.jhep.2010.03.011

Journal of Hepatology
Volume 53, Issue 2 , Pages 298-306 , August 2010

Article Tools

* Image Usage & Resolution